BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 12449040)

  • 1. [Gemcitabine and breast cancer].
    Besse B; Spano JP
    Bull Cancer; 2002 Aug; 89 Spec No():S107-14. PubMed ID: 12449040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gemcitabine in the treatment of advanced and metastatic breast cancer.
    Heinemann V
    Oncology; 2003; 64(3):191-206. PubMed ID: 12697958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine and targeted therapy in metastatic breast cancer.
    Qu G; Perez EA
    Semin Oncol; 2002 Jun; 29(3 Suppl 11):44-52. PubMed ID: 12138397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002) ].
    Gligorov J; André T; Epaud C; Culine S
    Bull Cancer; 2002 Aug; 89 Spec No():S134-44. PubMed ID: 12449045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platinum-free gemcitabine-based combinations: an alternative to conventional chemotherapy of non-small-cell lung cancers?].
    Pujol JL; Choma D; Jacot W; Quantin X
    Bull Cancer; 2002 Aug; 89 Spec No():S85-90. PubMed ID: 12449036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.
    O'Shaughnessy J
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):15-21. PubMed ID: 14768400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based pharmacoeconomic model for adopting capecitabine/docetaxel combination treatment for anthracycline-pretreated metastatic breast cancer.
    Verma S; Ilersich AL
    Oncologist; 2003; 8(3):232-40. PubMed ID: 12773745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of gemcitabine in metastatic breast cancer patients: a short review.
    Silvestris N; Cinieri S; La Torre I; Pezzella G; Numico G; Orlando L; Lorusso V
    Breast; 2008 Jun; 17(3):220-6. PubMed ID: 18037292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
    Cinieri S; Chan A; Altundag K; Vandebroek A; Tubiana-Mathieu N; Barnadas A; Dodyk P; Lazzarelli S; Botha M; Rauch D; Villanova G; Coskun U
    Clin Breast Cancer; 2017 Apr; 17(2):91-99.e1. PubMed ID: 27756583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for the use of gemcitabine in breast cancer (Review).
    Silvestris N; D'Aprile M; Andreola G; Locopo N; Marini L; Crucitta E; De Lena M; Lorusso V
    Int J Oncol; 2004 Feb; 24(2):389-98. PubMed ID: 14719116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Docetaxel (Taxotere) in combination with anthracycline, capecitabin (Xeloda) and new drugs].
    Galligioni E
    Tumori; 2001; 87(1 Suppl 2):S1-9. PubMed ID: 11357871
    [No Abstract]   [Full Text] [Related]  

  • 12. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New combinations with Herceptin in metastatic breast cancer.
    Winer EP; Burstein HJ
    Oncology; 2001; 61 Suppl 2():50-7. PubMed ID: 11694788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combinations of platinum salts and gemcitabine in the treatment of non-small-cell lung cancer].
    Souquet PJ; Gerinière L
    Bull Cancer; 2002 Aug; 89 Spec No():S80-4. PubMed ID: 12449035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gemicitabine in the treatment of epithelial ovarian cancer].
    Pautier P; Gutierrez M; Lhomme C
    Bull Cancer; 2002 Aug; 89 Spec No():S115-9. PubMed ID: 12449041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.
    Medioni J; Huchon C; Le Frere-Belda MA; Hofmann H; Bats AS; Eme D; Andrieu JM; Oudard S; Lecuru F; Levy E
    Drugs R D; 2011; 11(2):147-57. PubMed ID: 21679005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel/gemcitabine: salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer.
    Georgoulias VA
    Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):18-24. PubMed ID: 11252884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).
    Frasci G; Comella P; D'Aiuto G; Thomas R; Capasso I; Elmo M; Botti G; Cortino GR; Lapenta L; De Rosa V; Vallone P; Petrillo A; Comella G
    Ann Oncol; 2000 Mar; 11(3):367-71. PubMed ID: 10811508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Updates on gemcitabine on metastatic breast cancer].
    Gligorov J; Selle F; Khalil A; Abbas F; Namer M; Lotz JP
    Bull Cancer; 2007; 94 Spec No Actualites():S90-4. PubMed ID: 17845977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trastuzumab/chemotherapy combinations in metastatic breast cancer.
    Ligibel JA; Winer EP
    Semin Oncol; 2002 Jun; 29(3 Suppl 11):38-43. PubMed ID: 12138396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.